Market Research Logo

Global Botulinum Toxin and HA Dermal Filler Market Report: Insights, Trends and Forecast (2019-2023)

Global Botulinum Toxin and HA Dermal Filler Market Report: Insights, Trends and Forecast (2019-2023)

The global botulinum toxin & HA dermal filler market is estimated to reach US$11.06 billion in 2023, growing at a CAGR of 7.52%, for the period spanning from 2018 to 2023. The factors such as increasing urban population, growing ageing population, rising female workforce, escalating personal disposable income, evolving personal healthcare expenditure and growing number of plastic surgery and dermatology clinics are expected to drive the market growth. However, growth of the industry would be challenged by stringent regulations, patient health-associated risk and limited access to patent rights. A few notable trends include accelerating pharmaceutical R&D spending, progressing botulinum toxin products pipeline, rising minimally invasive procedures and growing preference for combination therapy.

Presently, botulinum toxin and HA dermal filler are widely used in therapeutics and aesthetics procedures for various purposes. Demand for these products was higher in therapeutic sector due to increasing approval of these injectables to manage nerve and muscular spasticity disorders by medicinal authorities.

The fastest growing regional market is North America owing to increasing geriatric population and rising demand for non-invasive aesthetic procedures in the US and Canada. The US is the largest market of botulinum toxin and HA dermal fillers and is already well-penetrated at developed market levels.

Scope of the report:

  • The report provides a comprehensive analysis of the global botulinum toxin and HA dermal filler market, segmented on the basis of applications i.e. therapeutics and aesthetics.
  • The major regional markets (North America, Europe and Asia-Pacific) have been analysed, along with country coverage of the U.S, Germany, Japan, Korea and China.
  • The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Allergan, Ipsen, Merz Pharma, Daewoong Pharmaceuticals, Medytox and Shanghai Haohai) are also presented in detail.
Key Target Audience:
  • Botulinum Toxin and HA Dermal Filler Manufacturers
  • Raw Material/Component Suppliers
  • End Users (Hospitals & Clinics)
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities


1. Market Overview
1.1 Aesthetics
Table 1: Aesthetics Procedure Categories
1.2 Botulinum Toxin
Table 2: Botulinum Toxin-A Major Product Description
1.3 HA Dermal Fillers
2. Global Aesthetics Market Analysis
2.1 Global Aesthetic Market Value Forecast
Table 4: Global Aesthetic Market Value Forecast (2018-2023)
2.2 Global Aesthetic Procedure Volume
Table 5: Global Aesthetic Procedure Volume (2014-2018)
2.3 Global Aesthetic Procedure Volume Forecast
Table 6: Global Aesthetic Procedure Volume Forecast (2019-2023)
2.4 Global Aesthetic Procedures by Types
Table 7: Global Aesthetic Procedures by Types (2018)
3. Global Botulinum Toxin & HA Dermal Filler Market Analysis
3.1 Global Botulinum Toxin Market Value
Table 8: Global Botulinum Toxin Market Value (2014-2018)
3.2 Global Botulinum Toxin Market Value Forecast
Table 9: Global Botulinum Toxin Market Value Forecast (2019-2023)
3.3 Global Botulinum Toxin Market Value by Application
Table 10: Global Botulinum Toxin Market Value by Application (2018)
3.3.1 Global Therapeutics Botulinum Toxin Market Value
Table 11: Global Therapeutics Botulinum Toxin Market Value (2014-2018)
3.3.2 Global Therapeutics Botulinum Toxin Market Value Forecast
Table 12: Global Therapeutics Botulinum Toxin Market Value Forecast (2019-2023)
3.3.3 Global Aesthetics Botulinum Toxin Market Value
Table 13: Global Aesthetics Botulinum Toxin Market Value (2014-2018)
3.3.4 Global Aesthetics Botulinum Toxin Market Value Forecast
Table 14: Global Aesthetics Botulinum Toxin Market Value Forecast (2019-2023)
3.4 Global Aesthetics Botulinum Toxin Procedures
Table 15: Global Aesthetics Botulinum Toxin Procedures (2014-2018)
3.5 Global Aesthetics Botulinum Toxin Procedures Forecast
Table 16: Global Aesthetics Botulinum Toxin Procedures Forecast (2019-2023)
3.6 Global Aesthetics Botulinum Toxin Procedures by Country
Table 17: Global Aesthetics Botulinum Toxin Procedures by Country (2018)
3.7 Global Botulinum Toxin Market Value by Region
Table 18: Global Botulinum Toxin Market Value by Region (2018)
3.8 Global Dermal Filler Market Value Forecast
Table 19: Global Dermal Filler Market Value Forecast (2018-2023)
3.9 Global Aesthetic Dermal Filler Procedures by Types
Table 20: Global Aesthetic Dermal Filler Procedures by Types (2018)
3.10 Global HA Dermal Filler Market Value
Table 21: Global HA Dermal Filler Market Value (2014-2018)
3.11 Global HA Dermal Filler Market Value Forecast
Table 22: Global HA Dermal Filler Market Value Forecast (2019-2023)
3.12 Global HA Dermal Filler Procedures
Table 23: Global HA Dermal Filler Procedures (2014-2018)
3.13 Global HA Dermal Filler Procedures Forecast
Table 24: Global HA Dermal Filler Procedures Forecast (2019-2023)
3.14 Global HA Dermal Filler Procedures by Country
Table 25: Global HA Dermal Filler Procedures by Country (2018)
4. Regional Botulinum Toxin & HA Dermal Filler Market Analysis
4.1 North America
4.1.1 North America Botulinum Toxin Market Value Forecast
Table 26: North America Botulinum Toxin Market Value Forecast (2018-2023)
4.1.2 The U.S. Botulinum Toxin Market Value
Table 27: The U.S. Botulinum Toxin Market Value (2014-2018)
4.1.3 The U.S. Botulinum Toxin Market Value Forecast
Table 28: The U.S. Botulinum Toxin Market Value Forecast (2019-2023)
4.1.4 The U.S. Botulinum Toxin Market Value by Application
Table 29: The U.S. Botulinum Toxin Market Value by Application (2018)
4.1.5 The U.S. Therapeutics Botulinum Toxin Market Value
Table 30: The U.S. Therapeutics Botulinum Toxin Market Value (2014-2018)
4.1.6 The U.S. Therapeutics Botulinum Toxin Market Value Forecast
Table 31: The U.S. Therapeutics Botulinum Toxin Market Value Forecast (2019-2023)
4.1.7 The U.S. Aesthetics Botulinum Toxin Market Value
Table 32: The U.S. Aesthetics Botulinum Toxin Market Value (2014-2018)
4.1.8 The U.S. Aesthetics Botulinum Toxin Market Value Forecast
Table 33: The U.S. Aesthetics Botulinum Toxin Market Value Forecast (2019-2023)
4.1.9 The U.S. Aesthetics Botulinum Toxin Procedures Forecast
Table 34: The U.S. Aesthetics Botulinum Toxin Procedures Forecast (2018-2023)
4.1.10 The U.S. HA Dermal Filler Procedures Forecast
Table 35: The U.S. HA Dermal Filler Procedures Forecast (2018-2023)
4.2 Europe
4.2.1 Europe Botulinum Toxin Market Value
Table 36: Europe Botulinum Toxin Market Value (2014-2018)
4.2.2 Europe Botulinum Toxin Market Value Forecast
Table 37: Europe Botulinum Toxin Market Value Forecast (2019-2023)
4.2.3 Europe Botulinum Toxin Market Value by Applications
Table 38: Europe Botulinum Toxin Market Value by Applications (2018)
4.2.4 Europe Therapeutics Botulinum Toxin Market Value
Table 39: Europe Therapeutics Botulinum Toxin Market Value (2014-2018)
4.2.5 Europe Therapeutics Botulinum Toxin Market Value Forecast
Table 40: Europe Therapeutics Botulinum Toxin Market Value Forecast (2019-2023)
4.2.6 Europe Aesthetics Botulinum Toxin Market Value
Table 41: Europe Aesthetics Botulinum Toxin Market Value (2014-2018)
4.2.7 Europe Aesthetics Botulinum Toxin Market Value Forecast
Table 42: Europe Aesthetics Botulinum Toxin Market Value Forecast (2019-2023)
4.2.8 Germany HA Dermal Filler Procedures Forecast
Table 43: Germany HA Dermal Filler Procedures Forecast (2018-2023)
4.3 Asia-Pacific
4.3.1 Asia-Pacific Botulinum Toxin Market Value Forecast
Table 44: Asia-Pacific Botulinum Toxin Market Value Forecast (2018-2023)
4.3.2 Japan Botulinum Toxin Market Value
Table 45: Japan Botulinum Toxin Market Value (2014-2018)
4.3.3 Japan Botulinum Toxin Market Value Forecast
Table 46: Japan Botulinum Toxin Market Value Forecast (2019-2023)
4.3.4 Korea Botulinum Toxin Market Value
Table 47: Korea Botulinum Toxin Market Value (2014-2018)
4.3.5 Korea Botulinum Toxin Market Value Forecast
Table 48: Korea Botulinum Toxin Market Value Forecast (2019-2023)
4.3.6 Korea Aesthetic Botulinum Toxin Market Volume Forecast
Table 49: Korea Aesthetic Botulinum Toxin Market Volume Forecast (2018-2023)
4.3.7 Korea HA Dermal Filler Market Value
Table 50: Korea HA Dermal Filler Market Value (2014-2018)
4.3.8 Korea HA Dermal Filler Market Value Forecast
Table 51: Korea HA Dermal Filler Market Value Forecast (2019-2023)
4.3.9 China HA Dermal Filler Market Value
Table 52: China HA Dermal Filler Market Value (2014-2018)
4.3.10 China HA Dermal Filler Market Value Forecast
Table 53: China HA Dermal Filler Market Value Forecast (2019-2023)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Urban Population
Table 54: Global Urban Population (2014-2018)
5.1.2 Growing Ageing Population
Table 55: Global Ageing Population (2014-2018)
5.1.3 Rising Female Workforce
Table 56: Global Working Women Population (2014-2018)
5.1.4 Escalating Personal Disposable Income
Table 57: Global GNI per Capita (2014-2018)
5.1.5 Evolving Personal HealthCare Expenditure
Table 58: Global Personal HealthCare Expenditure per Head (2014-2018)
5.1.6 Growing Plastic Surgery and Dermatology Clinics
Table 59: Korea Plastic Surgery and Dermatology Clinics (2014-2018)
5.2 Key Trends and Developments
5.2.1 Accelerating Pharmaceutical R&D Spending
Table 60: Global Pharmaceutical R&D Spending (2014-2018)
5.2.2 Progressing Botulinum Toxin Products Pipeline
Table 61: Upcoming Botulinum Toxin Product Launch by Region (2019-2023)
5.2.3 Rising Minimally Invasive Procedures in US
Table 62: The U.S. Minimally Invasive Procedures (2014-2018)
5.2.4 Growing Preference for Combination Therapy
5.3 Challenges
5.3.1 Stringent Regulations
5.3.2 Patient Health-Associated Risk
5.3.3 Limited Access to Patent Rights
6. Competitive Landscape
6.1 Global Botulinum Toxin and HA Dermal Filler Market
6.1.1 Key Players – Revenue Comparison
Table 63: Key Players – Revenue Comparison (2018)
6.1.2 Key Players – Market Cap Comparison
Table 64: Key Players – Market Cap Comparison (2019)
6.1.3 Key Players – Research & Development Expenditure Comparison
Table 65: Key Players – Research & Development Expenditure Comparison (2017-2018)
6.2 Global Botulinum Toxin Market
6.2.1 Key Players – Market Share Comparison
Table 66: Key Players – Global Botulinum Toxin Market Share Comparison (2018)
6.2.2 Key Players – Product Feature Comparison
Table 67: Key Players – Global Botulinum Toxin Product Feature Comparison (2018)
6.3 Global Dermal Filler Market
6.3.1 Key Players – Market Share Comparison
Table 68: Key Players – Global Dermal Filler Market Share Comparison (2018)
6.4 Global HA Dermal Filler Market
6.4.1 Key Players – Market Share Comparison
Table 69: Key Players – Global HA Dermal Filler Market Share Comparison (2018)
6.5 Regional Botulinum Toxin Market
6.5.1 Key Players – US Botulinum Toxin Market Share Comparison
Table 70: Key Players – US Botulinum Toxin Market Share Comparison (2018)
6.5.2 Key Players – Korea Botulinum Toxin Market Share Comparison
Table 71: Key Players – Korea Botulinum Toxin Market Share Comparison (2018)6.5.3 Key Players – China Botulinum Toxin Market Share Comparison
Table 72: Key Players – China Botulinum Toxin Market Share Comparison (2018)
6.6 Regional Dermal Filler Market
6.6.1 Key Players – Regional Dermal Filler Market Share Comparison
Table 73: Key Players – Regional Dermal Filler Market Share Comparison (2018)
6.7 Regional HA Dermal Filler Market
6.7.1 Key Players – Korea HA Dermal Filler Market Share Comparison
Table 74: Key Players – Korea HA Dermal Filler Market Share Comparison (2018)
6.7.2 Key Players – China HA Dermal Filler Market Share Comparison
Table 75: Key Players – China HA Dermal Filler Market Share Comparison (2018)
7. Company Profiles
7.1 Allergan Plc
7.1.1 Business Overview
7.1.2 Financial Overview
Table 76: Allergan Net Revenues and Net Income (Loss) (2014-2018)
Table 77: Allergan Net Revenues by Segments (2018)
Table 78: Allergan Net Revenues by Region (2018)
7.1.3 Business Strategies
7.2 Ipsen S.A.
7.2.1 Business Overview
7.2.2 Financial Overview
Table 79: Ipsen Net Sales and Net Profit (2014-2018)
Table 80: Ipsen Net Sales by Segments (2018)
Table 81: Ipsen Net Sales by Region (2018)
7.2.3 Business Strategies
7.3 Merz Pharma GmbH & Co. KGaA
7.3.1 Business Overview
7.3.2 Financial Overview
Table 82: Merz Pharma Revenues and Net Income (2014-2018)
Table 83: Merz Pharma Revenues by Region (2018)
7.3.3 Business Strategies
7.4 Daewoong Pharmaceuticals Co.
7.4.1 Business Overview
Table 84: Daewoong Pharmaceuticals Key Product Pipeline
7.4.2 Financial Overview
Table 85: Daewoong Pharmaceuticals Revenues and Net Income (Loss) (2014-2018)
7.4.3 Business Strategies
7.5 Medytox Inc.
7.5.1 Business Overview
7.5.2 Financial Overview
Table 86: Medytox Revenues and Net Profit (2014-2018)
7.5.3 Business Strategies
7.6 Shanghai Haohai Biological Technology Co. Ltd
7.6.1 Business Overview
Table 87: Shanghai Haohai Segment Overview
7.6.2 Financial Overview
Table 88: Shanghai Haohai Revenues and Net Profit (2014-2018)
Table 89: Shanghai Haohai Revenue by Segment (2018)
Table 90: Shanghai Haohai Revenue by Region (2018)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report